1.Clinical features and outcome in disseminated mycobacterial diseases
in AIDS patients in Taiwan: a prospective cohort study AIDS 1998;
2.Dynamics of plasma cytokine levels in patients with advanced HIV
infection and active tuberculosis: the implications for early
recognition of patients with poor response to anti-tuberculous
treatment AIDS 1999; 13: 935-41
3.Concomitant human Immunodeficiency virus infection and syphilitic
meningitis J Formos Med Assoc 1996; 95: 166-9.
4.Clinical features of tuberculosis associated with AIDS in Taiwan
J Formos Med Assoc 1996; 95: 923-8.
5.Intestinal obstruction and Peritonitis resulting from
gastrointestinal histoplasmosis in an AIDS patient J Formos Med
Assoc 1998; 97: 577-80.
6.Bacteremia and fungemia in patients with advanced HIV infection
in Taiwan J Formos Med Assoc 1998; 97: 690-7.
7.Efficacy and adverse effects of higher dose amphotericin B
monotherapy for cryptococcal meningitis in patients with
advanced HIV infection J Microbiol Immunol Infect 1998; 31:
8.Efficacy and safety of cefepime treatment in Chinese patients
wit severe bacterial infections: in comparison with
ceftazidime treatment Int J Antimicrob Agents 1998; 10: 245-8.
9.Antithyroid drug-induced agranulocytosis complicated by
life-threatening infections. Q J Med 1999; 92: 455-61.
10.The role of tissue studies in facilitating early initiation
of antimycobacterial treatment in AIDS patients with
disseminated mycobacterial diseases Int J Tuberc Lung Dis
1999; 3: 521-7.
11.Pattern of defervescence in response to anti-tuberculosis
therapy in patients with extrapulmonary tuberculosis and
advanced human immunodeficiency virus infection J Formos
Med Assoc 1999; 98: 550-555.
13.Ultrasound-guided percutaneous transthoracic needle aspiration
biopsy for diagnosis of pulmonary lesions in advanced HIV
infection J Formos Med Assoc 1999; 98: 195-200.
14.13Invasive amoebiasis: an emerging parasitic disease in
patients infected with HIV in an area endemic for amoebic
infection AIDS 1999; 13: 2421-8.
15.Oral fusidic acid fails to eradicate methicillin-resistant
Staphylococcus aureus colonization and results in emergence
of fusidic acid-resistant strains. Diagn Microbiol Infect Dis
2000; 36: 131-6.
16.Preliminary experience of adverse drug reactions,
tolerability and efficacy of a once-daily regimen of highly
active antiretroviral therapy. J AIDS 2000, June (in press).